A Novel

Mitchell Zhao, Nicholas Protopsaltis, Mina Sabet, Shulei Sun, Grace Lin, Farnaz Hasteh, Wei Song

Abstract readCase Reports

In one paragraph

Article in International journal of surgical pathology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mitchell ZhaoDepartment of Pathology and Laboratory Medicine, University of California San Diego, La Jolla, California, USA.

Nicholas ProtopsaltisDepartment of Pathology and Laboratory Medicine, University of California San Diego, La Jolla, California, USA.ORCID 0000-0002-1242-3014

Mina SabetDepartment of Pathology and Laboratory Medicine, University of California San Diego, La Jolla, California, USA.

Shulei SunDepartment of Pathology and Laboratory Medicine, University of California San Diego, La Jolla, California, USA.

Grace LinDepartment of Pathology and Laboratory Medicine, University of California San Diego, La Jolla, California, USA.

Farnaz HastehDepartment of Pathology and Laboratory Medicine, University of California San Diego, La Jolla, California, USA.

Wei SongDepartment of Pathology and Laboratory Medicine, University of California San Diego, La Jolla, California, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer genetics studies have dramatically advanced the understanding of the molecular drivers in various types of neoplasms. This progress is also leading to the discovery of more new molecular agents to block those drivers, which has significantly improved cancer patient survival, especially in non-small cell lung cancer (NSCLC). However, in about 25% of NSCLC tumors molecular drivers are not yet known. Herein, we present a poorly differentiated carcinoma involving lung and mediastinum. Next generation sequencing-based RNAseq identified a novel fusion,

Indexed as

Biomarkers, TumorCarcinoma, Non-Small-Cell LungLung NeoplasmsMediastinal NeoplasmsOncogene Proteins, FusionHigh-Throughput Nucleotide SequencingHumansLungMaleMediastinumMiddle AgedBiomarkers, TumorOncogene Proteins, Fusionpoorly differentiated carcinoma involving lungRPS6KB1 fusion

Identifiers

PMID40091373

DOI10.1177/10668969251323935

PMCPMC12276399

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.